Cytori Gains as Much as 21% After Contract Award

Sept. 28 (Bloomberg) -- Cytori Therapeutics, a biotechnology company with $10 million in annual revenue, rose the most in more than a year after the company won a $4.7 million U.S. government contract to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. Alix Steel reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Is Tesla’s Downgrade an Opportunity for Investors
37:48 - IDDS Group co-founder and CEO Max Zanan and Jefferies Analyst Dan Dolev discuss the Tesla being downgraded with Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Ukraine’s Jaresko: I'm Optimistic About Russia Bond Talks
  • Dell to Offer Data Storage Giant EMC $33 Per Share
  • Uber Closing In On 2014 Hack Suspect